Browsing Institutt for farmasi by Title

Now showing items 647-652 of 652

    • Zebrafish and safety pharmacology. Effects of ethanol on early brain and eye development. 

      Ali, Amina Mohammed (Master thesis; Mastergradsoppgave, 2014-05-21)
      Ethanol is well studied with regard to its teratogenic effects in different animal models including humans. Exposure of a fetus to alcohol during pregnancy can lead to fetal alcohol syndrome (FAS), or ethanol mediated toxicity in animal models. During early embryogenesis, development of the most important organs including the central nervous system (CNS) occurs. Disturbance of any function that ...

    • Zebrafish as a model system for safety pharmacology, using a glucocorticoid and an antimicrobial peptide as test substances 

      Albert, Ingrid (Master thesis; Mastergradsoppgave, 2013-05-20)
      The zebrafish is an exciting model organism with a lot to offer and many possible areas of application. Toxicity assays using zebrafish embryos are becoming increasingly popular with the pharmaceutical industry as a tool to bridge the gap between conventional cell based screens and animal testing. The main aim of this project was to explore the zebrafish as a model system for use in safety pharmacology, ...

    • ZN148 Is a Modular Synthetic Metallo-beta-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo 

      Samuelsen, Ørjan; Åstrand, Ove Alexander Høgmoen; Frøhlich, Christopher; Heikal, Adam; Skagseth, Susann; Carlsen, Trine Josefine Olsen; Leiros, Hanna-Kirsti S.; Bayer, Annette; Schnaars, Christian; Kildahl-andersen, Geir; Lauksund, Silje; Finke, Sarah; Huber, Sandra; Gjøen, Tor; Andresen, Adriana Magalhaes Santos; Økstad, Ole Andreas; Rongved, Pål (Journal article; Tidsskriftartikkel; Peer reviewed, 2020-05-21)
      Carbapenem-resistant Gram-negative pathogens are a critical public health threat and there is an urgent need for new treatments. Carbapenemases (β-lactamases able to inactivate carbapenems) have been identified in both serine β-lactamase (SBL) and metallo-β-lactamase (MBL) families. The recent introduction of SBL carbapenemase inhibitors has provided alternative therapeutic options. Unfortunately, ...

    • Zwitterionic antimicrobial nanoparticles for biofilm therapy 

      Phung, Anna Ngoc (Mastergradsoppgave; Master thesis, 2021-05-10)
      In recent years, many pathogenic bacteria have developed resistance against the existing antimicrobials, a phenomenon known as antimicrobial resistance (AMR). One of the many reasons contributing to the observed failure of current therapies, is the poor drug penetration across the microbial biofilm. Biofilms are small structural communities of bacterial cells that excrete an extracellular polymeric ...

    • α,α-disubstituted β-amino amides eliminate Staphylococcus aureus biofilms by membrane disruption and biomass removal 

      Ausbacher, Dominik; Miller, Lindsey A.; Goeres, Darla M.; Stewart, Philip S.; Strøm, Morten Bøhmer; Fallarero, Adyary (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-08-25)
      Bacterial biofilms account for up to 80% of all infections and complicate successful therapies due to their intrinsic tolerance to antibiotics. Biofilms also cause serious problems in the industrial sectors, for instance due to the deterioration of metals or microbial contamination of products. Efforts are put in finding novel strategies in both avoiding and fighting biofilms. Biofilm control is ...

    • β-cyclodextrin polymers as cholesterol sequestrating agents 

      Fadeev, Nikolay Olegovich (Master thesis; Mastergradsoppgave, 2018-08-19)
      Summary Elevated serum cholesterol blood levels is one of the central risk factors for cardiovascular diseases. Lowering blood cholesterol have significant impact on lowering cardiovascular disease events. Inhibiting cholesterol absorption in small intestine can significantly lower serum cholesterol levels and thereby - lower cardiovascular events. Β-cyclodextrin (βCD)-dextran polymer is expected ...